We got a few results today on the effects of piracetam and vision.
The results, showed that the glutamate increase in the synapses; (released in controlled amounts); showed that people experienced a higher perception of colour and detail who had normal and
slightly higher glutamate levels in the brain. The calcium ion channels (Ca
+ ions) were responsible for the release of the glutamate neurotransmitter. The study showed that people with
TOO MUCH Calcium in their neurons and post-synaptic space, experienced dulled/ normal perception of colour an detail; the same goes for the people who had
TOO LITTLE Calcium in their brain. It is like the 'U' shaped curve with experienced with Piracetam dosage.
Piracetam controls the release of Ca+ ions and glutamates in the brain, like previous studies have concluded, a dosage of 4.8 grams secretes the right amount of glutamate in the brain and regulates the Calcium ion channels. However, it was noticed that people who previously took Piracetam for more than 3 weeks required less dosage amounts of Piracetam (between 1000mg and 2800mg; some people exhibited the same effects when they took 4800mg) as compared to the new consumers.
The
private clinical trials proceeded as so:
The test was conducted between the period of Jan 15 and Feb 15. It consisted of 100 people, 50 of whom were regular piracetam consumers and had consumed it for over the 3 weeks while the other 50 were new consumers. The tests were carried out over the period of 4 weeks in a double-blind placebo controlled study. The first set of 25 people (consisting of previous piracetam consumers and new piracetam consumers) were given 4.8 grams of Piracetam with 300mg - 700mg of choline supplementation.
The second set of 25 people (also consisting of previous piracetam consumers and new piracetam consumers) were given 4.8 grams of Piracetam with 300mg - 700mg of Choline supplementation and 10mg - 100mg L-Glutamate supplementation.
The third set of 25 people (consisting of previous piracetam consumers and new piracetam consumers) were given Piracetam with 300mg - 700mg of Choline supplementation and 500mg L-Glutamate supplementation.
The Fourth set of 25 people (consisting of previous piracetam consumers and new piracetam consumers) were given placebo.
The results were recorded as so:
11 Previous Piracetam consumers and New Piracetam consumers in the first set experienced the 'enhanced vision' effect without glutamate supplementation. The other 14 people experienced no such effect ,however, they did feel the other effects that Piracetam provides (enhanced speech,cognitive function and music). The responders had regular a amount of glutamate in their brain (due to their diet). The non-responders lacked the glutamate levels and some lacked calcium ion levels.21 Previous Piracetam consumers and New Piracetam consumers in the second set reported the 'enhanced vision' effect. The other 4 did not respond. The responders showed slightly elevated glutamate levels in the brain, with a regular amount of calcium ions between post-synaptic spaces and neurons. The non - responders did not react due to insufficient amount of calcium ions in their brain.7 Previous Piracetam consumers and New Piracetam consumers reported the 'enhanced vision' effect.11 Previous Piracetam consumers and New Piracetam consumers did not report the 'enhanced vision' effect or any effect at all, 7 people reported the other benefits that Piracetam provides. The responders had a high amounts of glutamates in their brain but they also had a lower calcium ion concentration. The complete non-responders had too much glutamate in their brain with a regular concentration of calcium ions. the non-responders to the 'enhanced vision' but responders to the other effects had too much glutamate in their brain but the also had a slightly low concentration of calcium ions.All 25 Previous Piracetam consumers and New Piracetam consumers in the fourth set did not report anything (they were given a placebo).The conclusions made, were based on this report.
In other news our research team has cracked some small pieces for the 'Ultimate Nootropic' , the composition of which is
highly classified, but don't get your hopes up though, they are still a long way from cracking the components of the other 70% of the Nootropic. We are trying to get some of our results published in a few science magazines and also trying to catalog this information on a well known database. Wish us luck.
There is also an article that exhibits the effect of glutamates on the eyes.
http://www.ncbi.nlm....les/PMC2474471/